Fig. 4From: EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancerThe possibility that factors appear in prognostic models for PFS by the Bayesian Model Averaging method. EGFR mutations in post-treatment plasma (egfr.after) and new metastasis (new.met.site) factors present in most models (100% and 95%, respectively)Back to article page